Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04155 (
pS2
)
1,234
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The cochaperone
p23
plays an important role in estrogen receptor alpha (ER) signal transduction. In this study, we investigated how
p23
regulates ER target gene activation and affects tumor growth and progression. Remarkably, we found that changes in the expression of
p23
differentially affected the activation of ER target genes in a manner dependent upon the type of DNA regulatory element.
p23
overexpression enhanced the expression of the ER target genes cathepsin D and
pS2
, which are regulated by direct DNA binding of ER to estrogen response elements (ERE). In contrast, the expression of other target genes, including c-Myc, cyclin D1, and E2F1, to which ER is recruited indirectly through its interaction with other transcription factors remains unaffected by changes in
p23
levels. The
p23
-induced expression of
pS2
is associated with enhanced recruitment of ER to the ERE in the promoter, whereas ER recruitment to the ERE-less c-Myc promoter does not respond to
p23
. Intriguingly,
p23
-overexpressing MCF-7 cells exhibit increased adhesion and invasion in the presence of fibronectin. Our findings demonstrate that
p23
differentially regulates ER target genes and is involved in the control of distinct cellular processes in breast tumor development, thus revealing novel functions of this cochaperone.
...
PMID:The cochaperone p23 differentially regulates estrogen receptor target genes and promotes tumor cell adhesion and invasion. 1680 59